mRNA Center

The Pharmaceutical Development Department upholds SINOVAC’s mission of “providing vaccines to eliminate human diseases” .Through platform-based resource allocation and efficient collaboration mechanisms, it undertakes the development and quality research of various company products. Currently, the team has grown to 400 members, with laboratories and pilot plants covering a total of 55,700 square meters. It has three major process development platforms: the Vaccine Center, the mRNA Center and the Antibody Center. Additionally, it has comprehensive quality assurance, quality analysis and animal safety & efficacy evaluation systems, enabling the high-quality and efficient completion of preclinical research for innovative biological products.